Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation

[1]  E. Angov,et al.  Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation , 2014, Malaria Journal.

[2]  Michael D. Porter,et al.  Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint , 2013, Clinical and Vaccine Immunology.

[3]  Kristian E. Swearingen,et al.  Total and Putative Surface Proteomics of Malaria Parasite Salivary Gland Sporozoites* , 2013, Molecular & Cellular Proteomics.

[4]  Denise L. Doolan,et al.  Toward a Surrogate Marker of Malaria Exposure: Modeling Longitudinal Antibody Measurements under Outbreak Conditions , 2011, PloS one.

[5]  D. Doolan,et al.  Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults , 2011, Malaria Journal.

[6]  P. de la Vega,et al.  Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei , 2010, PloS one.

[7]  J. McCarthy,et al.  Using serological measures to monitor changes in malaria transmission in Vanuatu , 2010, Malaria Journal.

[8]  Teun Bousema,et al.  Identification of hot spots of malaria transmission for targeted malaria control. , 2010, The Journal of infectious diseases.

[9]  R. Snow,et al.  Serologic Markers for Detecting Malaria in Areas of Low Endemicity, Somalia, 2008 , 2010, Emerging infectious diseases.

[10]  L. Okell,et al.  Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, Plasmodium falciparum and Plasmodium vivax , 2010, PLoS pathogens.

[11]  J. Peltonen,et al.  Biennial Report of the Adaptive Informatics Research Centre 2008-2009 , 2010 .

[12]  J. Barnwell,et al.  High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model , 2009, PloS one.

[13]  A. Ghani,et al.  Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates , 2009, PloS one.

[14]  T. Bousema,et al.  Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania , 2009, BMC infectious diseases.

[15]  C. Whitty,et al.  Effect of Removing Direct Payment for Health Care on Utilisation and Health Outcomes in Ghanaian Children: A Randomised Controlled Trial , 2009, PLoS medicine.

[16]  Teun Bousema,et al.  Dried blood spots as a source of anti-malarial antibodies for epidemiological studies , 2008, Malaria Journal.

[17]  T. Gebre,et al.  Evaluation of light microscopy and rapid diagnostic test for the detection of malaria under operational field conditions: a household survey in Ethiopia , 2008, Malaria Journal.

[18]  Chris Drakeley,et al.  Serology: a robust indicator of malaria transmission intensity? , 2007, Trends in parasitology.

[19]  F. McKenzie,et al.  Parasite prevalence: a static measure of dynamic infections. , 2007, The American journal of tropical medicine and hygiene.

[20]  T. Bousema,et al.  Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania , 2006, Malaria Journal.

[21]  L. H. Carvalho,et al.  Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. , 2006, The American journal of tropical medicine and hygiene.

[22]  J. Gyapong,et al.  Feasibility and acceptability of the use of artemether‐lumefantrine in the home management of uncomplicated malaria in children 6–59 months old in Ghana , 2006, Tropical medicine & international health : TM & IH.

[23]  Y. Chinzei,et al.  CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts , 2006, Molecular microbiology.

[24]  J. Cox,et al.  Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. , 2005, The Journal of infectious diseases.

[25]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Weltgesundheitsorganisation.  World malaria report , 2005 .

[27]  S. Kappe,et al.  Differential transcriptome profiling identifies Plasmodium genes encoding pre‐erythrocytic stage‐specific proteins , 2004, Molecular microbiology.

[28]  M. Tanner,et al.  An estimation of the entomological inoculation rate for Ifakara: a semi‐urban area in a region of intense malaria transmission in Tanzania , 2003, Tropical medicine & international health : TM & IH.

[29]  John Sidney,et al.  Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  James L Regens,et al.  Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. , 2003, The American journal of tropical medicine and hygiene.

[31]  S. Adjei,et al.  Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. , 2002, Social science & medicine.

[32]  L. H. Carvalho,et al.  Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas. , 2002, The American journal of tropical medicine and hygiene.

[33]  C. Ockenhouse,et al.  Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked Plasmodium vivax Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in Escherichia coli , 2001, Infection and Immunity.

[34]  D. Evans,et al.  Improving adherence to malaria treatment for children: the use of pre‐packed chloroquine tablets vs. chloroquine syrup , 2001, Tropical medicine & international health : TM & IH.

[35]  L. Manderson,et al.  MOSQUITO AVOIDANCE AND BED NET USE IN THE GREATER ACCRA REGION, GHANA , 1999, Journal of Biosocial Science.

[36]  É. Braga,et al.  Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax. , 1998, The Journal of infectious diseases.

[37]  E. Afari,et al.  Malaria infection, morbidity and transmission in two ecological zones Southern Ghana. , 1995, African journal of health sciences.

[38]  J. Baird.  Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. , 1995, Parasitology today.

[39]  K. Nagendran,et al.  Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka. , 1994, The American journal of tropical medicine and hygiene.

[40]  C. Dye,et al.  Maximum likelihood for parasitologists. , 1994, Parasitology today.

[41]  H. Webster,et al.  Circumsporozoite antibody as a serologic marker of Plasmodium falciparum transmission. , 1992, The American journal of tropical medicine and hygiene.

[42]  O. Pradier,et al.  Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection , 1986, Infection and immunity.

[43]  W H TALIAFERRO,et al.  Acquired immunity in malaria. , 1948, Abstracts. International Congress on Tropical Medicine and Malaria.